Neogen Income Statement
NEOG / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 12.9% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $894.7M | $924.2M | $822.4M | $527.2M | $468.5M | $418.2M | $414.2M | $397.9M | $358.3M | $321.3M | $283.1M | $247.4M | $207.5M | $184.0M |
| Cost of Revenue | - | $473.3M | $460.3M | $416.5M | $284.1M | $253.4M | $221.9M | $222.3M | $211.7M | $189.4M | $168.2M | $143.4M | $124.8M | $98.0M | $91.6M |
| Gross Profit | - | $421.4M | $463.9M | $406.0M | $243.0M | $215.1M | $196.3M | $191.9M | $186.3M | $168.9M | $153.1M | $139.7M | $122.6M | $109.5M | $92.4M |
| SG&A Expense | - | $218.2M | $199.9M | $201.2M | $82.7M | $51.2M | $44.3M | $40.8M | $38.3M | $34.2M | $29.2M | $25.2M | $24.4M | $20.2M | $17.0M |
| R&D Expense | - | $21.1M | $22.5M | $26.0M | $17.0M | $16.2M | $14.8M | $12.8M | $10.9M | $10.4M | $9.9M | $9.6M | $8.3M | $7.8M | $6.6M |
| Operating Income | - | -$1.1B | $58.7M | $37.5M | $58.6M | $74.2M | $67.5M | $68.1M | $70.2M | $64.9M | $56.4M | $53.1M | $43.4M | $40.7M | $33.7M |
| Interest Expense | - | $38.1M | $42.2M | $27.3M | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | -$41.1M | -$4.9M | $828.0K | $11.9M | $14.4M | $12.8M | $12.8M | $10.3M | $22.7M | $19.0M | $18.5M | $15.0M | $14.1M | $11.4M |
| Net Income | - | -$1.1B | -$9.4M | -$22.9M | $48.3M | $60.9M | $59.5M | $60.2M | $63.1M | $43.8M | $36.6M | $33.5M | $28.2M | $27.2M | $22.5M |
| EPS (Basic) | -$0.12 | $0.45 | $0.57 | $0.57 | $0.58 | $1.23 | $0.87 | $0.73 | $0.91 | $0.77 | $0.76 | $0.64 | $0.99 | $0.78 | $0.64 |
| EPS (Diluted) | -$0.12 | $0.45 | $0.57 | $0.56 | $0.57 | $1.21 | $0.86 | $0.72 | $0.90 | $0.76 | $0.75 | $0.62 | $0.96 | $0.76 | $0.62 |
| Shares Outstanding | 217.0M | 216.2M | 107.8M | 107.5M | 105.9M | 52.2M | 51.7M | 50.9M | 37.6M | 37.1M | 36.7M | 36.1M | 23.6M | 23.3M | 36.0M |
| Gross Margin | - | 47.1% | 50.2% | 49.4% | 46.1% | 45.9% | 46.9% | 46.3% | 46.8% | 47.1% | 47.6% | 49.4% | 49.5% | 52.8% | 50.2% |
| Operating Margin | - | -118.6% | 6.3% | 4.6% | 11.1% | 15.8% | 16.2% | 16.4% | 17.6% | 18.1% | 17.5% | 18.8% | 17.5% | 19.6% | 18.3% |
| Profit Margin | - | -122.1% | -1.0% | -2.8% | 9.2% | 13.0% | 14.2% | 14.5% | 15.9% | 12.2% | 11.4% | 11.8% | 11.4% | 13.1% | 12.2% |